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ABSTRACT
Objectives: Current evidence suggests that subclinical inflammation plays a significant role in the development of hy-
peremesis gravidarum (HEG). Simple hematological markers, such as mean platelet volume (MPV), neutrophil-to-lymphocyte 
ratio (NLR), and platelet-to-lymphocyte ratio (PLR), have been shown to reflect inflammatory burden and disease activity in 
several disorders. This study aimed to determine the diagnostic value of these hematological parameters for HEG.
Material and methods: A total of 54 HEG patients and 58 age- and gestational-age-matched control subjects were studied. 
NLR, MPV, PLR, platelet distribution width (PDW), and red cell distribution width (RDW) values in all patients were calculated 
and recorded from complete blood cell counts. 
Results: For HEG patients, the median NLR was 3.2 (1.6–7.1), and the median PLR was 143.7 (78.1–334.6); for control sub-
jects, the values were 2.1 (1.0–4.7) and 93.1 (47.3–194.7), respectively. Although both the NLR and PLR of HEG patients were 
found to be significantly higher than in the controls, no significant difference was found between the study groups in terms 
of MPV, RDW, or PDW. Correlation analysis revealed a significant correlation between NLR and CRP (r = 0.872, p < 0.001). 
Conclusions: Our results show that peripheral blood NLR and PLR values can reflect inflammatory burden in HEG patients 
and can be used as markers for HEG. 
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INTRODUCTION
Hyperemesis gravidarum (HEG) is a medical condition of 
intractable vomiting during pregnancy; it has a multifactorial 
etiology and affects approximately 0.3–2% of all pregnan-
cies [1]. In general, HEG occurs in the first trimester of preg-
nancy, but it can be seen as late as the twentieth week. Due to 
life-threatening complications such as weight loss, ketonuria, 
and electrolyte imbalance, it often requires hospitalization [2]. 
The exact pathophysiological basis of HEG is controver-
sial and associated with multiple risk factors. HEG appears to 
begin with a complex interaction of various factors, includ-
ing physiological, biological, and sociocultural factors. Hor-
monal changes (including high human chorionic gonado-
tropin [hCG] levels that cause transient hyperthyroidism), 
gastrointestinal dysfunction, hepatic dysfunction, metabolic 
derangements, lipid alterations, Helicobacter pylori infec-
tion, and genetic susceptibility have all been proposed to 
explain the underlying mechanisms of this potentially seri-
ous condition [3, 4]. Although current data are inadequate 
to describe the role of inflammation in HEG pathogenesis, 
it seems likely that subclinical inflammation plays a causal 
role in HEG development [5, 6]. The major pro-inflammatory 
cytokines, such as IL-6 and TNF-α, which are responsible 
for early inflammatory responses, are found to be elevated 
in HEG patients; this supports an inflammation-induced 
dysregulation of the biological system [6, 7].
Different hematological parameters have been used to 
evaluate the inflammatory status of distinct disease states 
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in recent years [8, 9]. Mean platelet volume (MPV), platelet 
distribution width (PDW), neutrophil-to-lymphocyte ratio 
(NLR), red cell distribution width (RDW) and platelet-to-lym-
phocyte ratio (PLR) are simple markers that have been 
shown to reflect inflammatory burden and disease activity 
in several disorders, including ulcerative colitis, spontane-
ous bacterial peritonitis, malignancies, and cardiovascular 
diseases [10, 11]. With this background, the present study 
was undertaken to investigate the diagnostic value of MPV, 
PDW, NLR, RDW, and PLR in HEG patients and their correla-
tion with other inflammatory markers as indices of subclini-
cal inflammation.
MATERIAL AND METHODS
A total of 54 pregnant women with HEG, at 6–13 weeks 
gestation, and 58 pregnant controls without any complaints 
and matched for gestational age were recruited for this 
study. The inclusion criteria for HEG patients were as fol-
lows: persistent nausea and vomiting, loss of more than 5% 
of body weight, the presence of at least one positive ke-
tonuria test in a random urine specimen, and a singleton 
pregnancy. Patients with a history of ovulation induction, 
eating disorders, multiple gestation, cigarette smoking, 
gastrointestinal disorders, thyroid disorders, or urinary tract 
infections were excluded from the study. The control group 
consisted of pregnant women without any complaints or 
chronic or inflammatory disorders, matched for gestational 
age with the study group. The study was approved by the 
ethics committee of Canakkale Onsekiz Mart University and 
was conducted in accordance with the guidelines of the 
Helsinki Declaration.
The following data were recorded for each patient: age, 
body-mass index (BMI), gestational age, gravidity, and parity. 
The gestational age of the women was determined by using 
the first date of the last menstrual period and confirmed 
by ultrasonography. BMI was calculated by dividing body 
weight by the square of height in meters.
All blood samples were collected without anticoagu-
lant use from the antecubital vein after an overnight fast. 
Complete blood count (CBC), erythrocyte sedimentation 
rate (ESR), and C-reactive protein (CRP) values were also 
recorded for each patient. All CBC analyses were performed 
in the hematology laboratory of our hospital using the same 
Beckman Coulter (High Wycombe, UK) Gen-S automated 
analyser for all samples.
CBC parameters, including white blood cell (WBC) count, 
neutrophil count, lymphocyte count, hemoglobin (Hb), 
platelet count (Plt), MPV, PDW, and RDW, were all derived 
from patients’ files. The NLR was calculated from the dif-
ferential count by dividing the absolute neutrophil count 
by the absolute lymphocyte count; the PLR was calculated 
by dividing the platelet count by the lymphocyte count. 
The primary goal of the study was to define a clinical re-
lationship between MPV, NLR, PDW, PLR and RDW values and 
the presence of HEG. The secondary goal was to evaluate 
whether there is a correlation between these hematologic 
indices and other conventional inflammatory markers. 
Statistical analysis
Statistical Package for Social Sciences (Version 18, SPSS 
Inc., Chicago, IL, USA) for Windows was used to analyse 
the data. Continuous variables were tested for normality 
with the Kolmogorov-Smirnov test. All normally distrib-
uted data were compared using Student’s t test. Data found 
to be non-normally distributed were compared using the 
Mann-Whitney U test. Data are expressed as mean ± stand-
ard deviation or median (min–max). Receiver operating 
characteristic (ROC) curve analysis was used to identify the 
optimal cut-off values of NLR and PLR that detect HEG with 
maximum sensitivity and speciﬁcity. Spearman correlation 
analysis used for evaluation of a possible correlation be-
tween distinct variables. P values below 0.05 were consid-
ered to be statistically signiﬁcant.
RESULTS
Fifty-four patients with HEG and 58 control subjects 
were enrolled in the study. No statistically significant dif-
ferences were observed in age, BMI, or gestational age be-
tween the two groups. Clinical characteristics of the study 
groups are summarized in Table 1. 
Table 1. Demographic features of the patients and controls
Hyperemesis gravidarum
(n = 54)
Control groups
(n = 58) p
Age (years) 25 (17–43) 27 (19–44) NS**
BMI [kg/m2] 23.67 ± 3.21 24.22 ± 3.78 NS*
Gestational age (weeks) 9 (7–13) 9 (7–12) NS**
Gravidity 2 (1–4) 2 (1–5) NS**
Parity 1 (0–3) 1 (0–4) NS**
Notes: *Student’s t test and **Mann-Whitney U test was applied. The data were presented either as median (min–max) or mean ± standard deviation; NS — not 
significant; BMI — body mass index
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For HEG patients, the median NLR was 3.2 (1.6–7.1), and 
the median PLR was 143.7 (78.1–334.6); for control subjects, 
the values were 2.1 (1.0–4.7) and 93.1 (47.3–194.7), respec-
tively. NLR and PLR values of HEG patients were significantly 
higher than those of the controls (p < 0.001 for both NLR and 
PLR). Mean MPV, PDW, and RDW values in HEG patients were 
not significantly different from the controls (Tab. 2). Although 
not found to be statistically significant, a pattern of increased 
CRP levels was seen in HEG patients. No significant difference 
was seen in ESR or WBC levels between study groups (Tab. 2).
ROC curve analysis suggested that the optimum NLR 
cut-off point for HEG was 2.38; the sensitivity, specificity, 
positive predictive value (PPV), and negative predictive 
value (NPV) were 70.6%, 79.6%, 78.8%, and 71.7%, respec-
tively (AUC: 0,818). The optimum PLR cut-off point for HEG 
was 100.4; sensitivity, specificity, PPV, and NPV were 60.3 %, 
94.4%, 92.1%, and 68.9 %, respectively (AUC: 0,817).
Although Spearman correlation analysis indicated 
a significant correlation between NLR and CRP (r = 0,872, 
p < 0,001; Figure 1), no correlation was found between ESR 
and WBC (Tab. 3).
DISCUSSION
The main aim of the present study was to evaluate the 
diagnostic value of MPV, NLR, RDW, PDW and PLR for HEG. 
We also sought a possible association between these mark-
ers and conventional inflammation markers such as CRP, ESR, 
and WBC. Our findings revealed that only NLR and PLR levels 
were higher in HEG patients than in controls. Also, only CRP 
levels were found to be correlated with NLR levels. NLR val-
ues were found to have high sensitivity, specificity, and pre-
dictive value in differentiating HEG patients from controls. 
Though the role of inflammation in HEG pathophysiol-
ogy is currently unclear, it is thought that oxidative stress, 
which accompanies subclinical inflammation, may play 
an important role [6, 12]. Kaplan et al. [7] evaluated serum 
cytokine levels in HEG patients as markers of inflammation; 
serum levels of TNF-α, which is a pleiotropic inflammatory 
cytokine produced by many cell types, were found to be el-
evated in HEG patients compared with healthy pregnant and 
Table 2. Baseline laboratory values of the patients and controls
Hyperemesis gravidarum
(n = 54)
Control groups
(n = 58) p
Hemoglobin [g/dL] 12.5 (9.7–14.7) 12.7 (10.2–13.9) NS**
WBC [/mm3 ×103] 8.6 ± 1.8 8.7 ± 1.8 NS*
Platelet [/mm3 ×103] 258.5 (138.0–437.0) 262.0 (161.0–409.0) NS**
MPV [fL] 8.7 (6.7–11.0) 8.8 (7.2–11.0) NS**
PDW (%) 16.3 (15.6–18.1) 16.2 (11.9–17.8) NS**
RDW (%) 12.1 ± 1.4 12.6 ± 1.7 NS*
NLR 3.2 (1.6–7.1) 2.1 (1.0–4.7) < 0.001**
PLR 143.7 (78.1–334.6) 93.1 (47.3–194.7) < 0.001**
CRP [mg/L] 5.9 (0.2–31.0) 4.2 (0.5–57.8) NS**
ESR [mm/h] 13.5 (2.0–47.0) 16.0 (2.0–44.0) NS**
Notes: *Student’s t test and **Mann-Whitney U test was applied. The data were presented either as median (min–max) or mean ± standard deviation; NS — not significant
Table 3. Spearman correlation coefficients between NLR and PLR 
with other inflammation markers in HEG patients
CRP ESR WBC
NLR
rs 0.872 0.263 0.476
p < 0.001 0.065 0.071
PLR
rs 0.299 0.188 –0.116
p 0.058 0.192 0.402
40
30
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0
CR
P 
[m
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L]
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R2 Linear = 0.76
NLR
Figure 1. The correlation between neutrophil to lymphocyte ratio 
(NLR) and CRP. Lines representing the 95% conﬁdence interval (CI) 
and the 95% prediction interval of the regression line
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nonpregnant women. In a recent study by Engin-Ustun et al. 
[5], serum vaspin and CRP levels were found to be elevated 
in HEG patients. A novel adipokine with insulin-sensitizing 
effects, vaspin acts as a pro-inflammatory cytokine, and 
elevated levels of vaspin in conjunction with elevated CRP 
levels support the idea of HEG as an inflammatory disorder 
[13]. Despite the well-known roles of these inflammatory 
markers in HEG pathogenesis, there are only scarce data in 
the literature describing the role of hematological markers 
in HEG pathogenesis. Therefore, this study was designed 
to evaluate the role of distinct hematological parameters, 
including NLR, MPV, RDW, PDW, and PLR in HEG patients, in 
conjunction with other conventional inflammatory markers. 
The elevated NLR and PLR levels seen in our study could 
be the consequence of a physiological immune response of 
circulating leucocytes to HEG-associated physical stress, which 
results in amplification of neutrophils and a decrease in lym-
phocyte counts. In fact, this is the main reason that elevated 
NLR and PLR levels are found in peripheral blood analyses in all 
inflammatory disorders. In this context, NLR and PLR could be 
regarded as simple, inexpensive, and effective inflammation 
markers that have been linked with several inflammatory and 
neoplastic diseases [8]. Recent studies have shown that NLR 
and PLR values are strongly associated with the diagnosis and 
prognosis of ulcerative colitis, tubo-ovarian abscesses, familial 
Mediterranean fever, brucella arthritis, and colorectal cancer 
[8, 14–18]. Although PLR changes in HEG patients have not 
been studied previously, two recent studies demonstrated 
that NLR levels are increased and correlated in patients with 
HEG [6, 19]. However, these studies did not compare the 
accuracy of the results with other hematological and inflam-
matory markers besides hsCRP. 
Platelet size has been shown to be associated with plate-
let activation. Increases in platelet activation can be mea-
sured by MPV and PDW [20, 21]. MPV is a measure of platelet 
size that shows platelet function and activation and can be 
measured by full blood count analysers as part of a routine 
CBC test cycle, with no additional cost [22]. It is one of the 
most widely used surrogate markers of platelet function and 
has been shown to reflect inflammatory burden and disease 
activity in several disease conditions, such as myocardial 
infarction, ulcerative colitis, familial Mediterranean fever, 
rheumatoid arthritis, acute ischemic stroke, and acute pan-
creatitis [23–25]. An extensive literature search revealed 
that no correlations have been studied in the analysis of 
MPV and PDW as hematological markers for HEG. Based 
on data showing that MPV and PDW values are associated 
with inflammation, we investigated if any alterations in 
MPV and PDW exist during the clinical course of HEG. We 
found no significant difference in MPV and PDW in HEG pa-
tients compared to controls, suggesting that there are other 
pathogenetic mechanisms in HEG than platelet activation. 
RDW seems to be a predictor for a wide range of condi-
tions, due to systemic factors such as inflammation and 
oxidative stress that alter erythrocyte homeostasis [26]. 
Inflammation might contribute to elevated levels of RDW 
not only by inhibiting the production of or response to 
erythropoietin, but also by impairing iron metabolism [27]. 
In our study, we found no significant difference in RDW levels 
between study groups. Moreover, no significant association 
between inflammation markers and RDW was observed. 
There are some limitations of the present study that 
should be studied in future clinical investigations. The first 
major limitation of our study is the negligence of other 
well-demonstrated inflammatory markers such as TNF-α, 
IL-6 and IL-1β. It would be worthwhile to study serum levels 
of these pro-inflammatory cytokines. Moreover, a correlation 
analysis between these cytokines and hematological mark-
ers could help to reveal the underpinnings of pathogenetic 
mechanisms that are difficult to discover otherwise. A sec-
ond limitation is that, despite our findings, our results should 
be interpreted cautiously, because the relatively moderate 
sample size limited the power of the study. Finally, it would 
have been useful to evaluate the same HEG patients after 
clinical remission was achieved. 
In conclusion, according to the results of the present 
study, although NLR and PLR can be considered efficient 
markers of disease, it is not certain whether high values of 
these markers are the result of a compensatory mechanism 
in response to HEG or if they reflect subclinical inflamma-
tion. A larger-scale, prospective clinical study should be 
conducted to further evaluate the diagnostic and prognostic 
significance of these hematological markers in HEG patients.
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